...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Notice anything different about #11
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Hey tada, I just looked at clinicaltrials.gov and the last update to that trial was a year ago and there was no partner then, just Memorial Sloan Kettering and Zenith. Who and when was the partner you are referring to?

1 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply